The Covid-19 Early Treatment Fund was launched to provide funding for research in order to "find an existing drug or drug combination that, when given early, reduces hospitalization…
In an interview for NBC News, Vin Gupta, MD, MPA, MSc, affiliate assistant professor of Health Metrics Sciences at the Institute for Health Metrics and Evaluation (IHME) at…
NEW YORK (Reuters Health) Some men having coronary artery bypass graft surgery (CABG) especially smokers — should also be screened for abdominal aortic aneurysms (AAA), even if they’re…
NEW YORK (Reuters Health) Heart failure patients who see a physician within a week after hospital discharge are less likely to be readmitted within 30 days, according to…
NEW YORK (Reuters Health) – Statins reduce the risk of new-onset atrial fibrillation after myocardial infarction or revascularization, new data confirm. “This may be yet another reason why…
NEW YORK (Reuters Health) – Does vaccination against pneumococcal pneumonia reduce the risk of acute myocardial infarction (MI) or stroke? Apparently not, according to a study of more…
NEW YORK (Reuters Health) – A single dose of azithromycin cured early syphilis as effectively as the standard painful penicillin injections, in a recent phase III trial. But…
NEW YORK (Reuters Health) – Plasma levels of the cardiac hormone N-terminal pro-B-type natriuretic peptide (NT-proBNP) don’t tell doctors anything about their normal healthy patients, new research shows.…
NEW YORK (Reuters Health) – Recombinant human neuregulin-1 (rhNRG-1) improves cardiac function and remodeling in patients with chronic heart failure (CHF), say researchers from the People’s Republic of…
NEW YORK (Reuters Health) – In patients with chronic kidney disease (CKD) and anemia, targeting higher hemoglobin levels with an erythropoietic agent is not helpful and is very…
NEW YORK (Reuters Health) – Coronary artery stenting does not reduce long-term rates of myocardial infarction (MI) or mortality in patients with stress-positive stable coronary artery disease, German…
NEW YORK (Reuters Health) – Up to 20% of tests for estrogen and progesterone receptors in breast cancers are false negatives or false positives, according to a consensus…
